Evidence map›Paper›PMID 24797558›Full record

ReviewJournal of inherited metabolic disease2014

Modelling inborn errors of metabolism in zebrafish.

Kim Wager, Fahad Mahmood, Claire Russell

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of inherited metabolic disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Inborn errors of metabolism: Lessons from iPSC models.Reviews in endocrine & metabolic disorders · 2021
    Review
  2. Article
  3. Article
  4. Review
  5. Flux analysis of inborn errors of metabolism.Journal of inherited metabolic disease · 2018
    Review
  6. Article
  7. Article
  8. Review
  9. New zebrafish models of neurodegeneration.Current neurology and neuroscience reports · 2015
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kim WagerDepartment of Comparative Biomedical Sciences, Royal Veterinary College, Royal College Street, London, NW1 0TU, UK.
Fahad Mahmood
Claire Russell

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The majority of human inborn errors of metabolism are fatal multisystem disorders that lack proper treatment and have a poorly understood mechanistic basis. Novel technologies are required to address this issue, and the use of zebrafish to model these diseases is an emerging field. Here we present the published zebrafish models of inborn metabolic diseases, discuss their validity, and review the novel mechanistic insights that they have provided. We also review the available methods for creating and studying zebrafish disease models, advantages and disadvantages of using this model organism, and successful examples of the use of zebrafish for drug discovery and development. Using a zebrafish to model inborn errors of metabolism in vivo, although still in its infancy, shows promise for a deeper understanding of disease pathomechanisms, onset, and progression, and also for the development of specific therapies.

Indexed as

Disease Models, AnimalZebrafishAnimalsDrug DiscoveryEmbryo, NonmammalianHumansMetabolism, Inborn ErrorsMolecular Targeted TherapyValidation Studies as Topic

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.